Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DCGO
DCGO logo

DCGO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.647
Open
0.600
VWAP
0.63
Vol
608.43K
Mkt Cap
59.24M
Low
0.600
Amount
381.18K
EV/EBITDA(TTM)
--
Total Shares
98.75M
EV
7.04M
EV/OCF(TTM)
0.20
P/S(TTM)
0.18
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.
Show More

Events Timeline

(ET)
2026-03-16
16:20:00
DocGo Q4 Revenue at $74.9M, Exceeds Expectations
select
2025-11-10 (ET)
2025-11-10
16:08:04
DocGo projects FY26 revenue between $280M and $300M, below consensus estimate of $317.78M.
select
2025-11-10
16:07:28
DocGo updates FY25 revenue forecast to a range of $315M-$320M, down from $300M-$330M.
select
2025-11-10
16:06:23
DocGo Announces Q3 EPS of 28 Cents Compared to 5 Cents Last Year
select
2025-10-20 (ET)
2025-10-20
17:25:36
DocGo purchases virtual healthcare platform SteadyMD
select
2025-08-07 (ET)
2025-08-07
16:50:16
DocGo backs FY25 revenue view of $300M-$330M, consensus $.
select

News

Newsfilter
2.0
03-18Newsfilter
DocGo Recognized as One of the 2026 World's Most Ethical Companies
  • Ethical Recognition: DocGo Inc. has been honored by Ethisphere as one of the 2026 World's Most Ethical Companies, highlighting the company's exceptional performance in ethics and compliance within the healthcare sector, thereby enhancing its reputation and competitive edge in the industry.
  • Industry Leadership: As one of only four honorees in the healthcare providers category, DocGo's recognition among 138 awardees underscores its unique position and further solidifies its leadership in the medical technology field.
  • Governance and Compliance Strengthening: Chief Compliance Officer Stephen Sugrue emphasized that DocGo's efforts in governance, risk, and compliance have made ethical behavior central to daily decision-making, improving overall operational efficiency and employee satisfaction.
  • Commitment to Continuous Improvement: CEO Lee Bienstock stated that the company will continue to focus on strong governance and transparency to ensure that ethics and integrity remain paramount in the rapidly evolving healthcare landscape, thus driving long-term business success.
seekingalpha
9.5
03-17seekingalpha
DocGo Inc. Reports Q4 2025 Earnings Highlights
  • Revenue Performance: DocGo reported $74.9 million in Q4 2025 revenue, down from $120.8 million in Q4 2024, primarily due to the wind-down of migrant-related projects, highlighting the challenges and opportunities in the company's transformation process.
  • EBITDA Loss Improvement: The adjusted EBITDA loss was $11.6 million, with management projecting a reduction to $5 million to $10 million in 2026, reflecting positive progress in cost control and operational efficiency.
  • SteadyMD's Strong Performance: SteadyMD exceeded $8 million in revenue for the first time in Q4, driving overall revenue growth and expected to continue as a key growth driver for the company in 2026.
  • Exploration of Strategic Alternatives: DocGo has initiated a process to explore various strategic alternatives aimed at maximizing shareholder value, demonstrating management's proactive approach to future developments and sensitivity to market changes.
NASDAQ.COM
2.0
03-16NASDAQ.COM
DocGo (DCGO) Q4 2025 Earnings Call Transcript
seekingalpha
9.5
03-16seekingalpha
DocGo Q4 Earnings Report Analysis
  • Disappointing Earnings: DocGo reported a Q4 GAAP EPS of -$1.37, missing estimates by $1.23, indicating a significant decline in profitability that could negatively impact investor confidence.
  • Revenue Performance: The total revenue for Q4 was $74.9 million, beating expectations by $4.54 million, although overall performance still lags behind last year, reflecting growth potential in specific business areas.
  • Widening Net Loss: The net loss for Q4 reached $142.3 million, a substantial increase from $7.6 million in the same quarter last year, primarily due to $78 million in non-cash items, highlighting challenges in asset management.
  • Cash Flow Situation: As of December 31, 2025, the company held approximately $68.3 million in cash and cash equivalents, a significant drop from $95.2 million as of September 30, 2025, reflecting liquidity pressure from the acquisition of SteadyMD and related transaction payments.
PRnewswire
7.0
03-12PRnewswire
Halper Sadeh LLC Investigates DocGo Executives' Fiduciary Duties
  • Shareholder Rights Protection: Halper Sadeh LLC is investigating whether DocGo Inc. executives breached their fiduciary duties, allowing shareholders to seek legal remedies within a limited timeframe to ensure corporate governance reforms and fund recovery.
  • Legal Fee Arrangement: The firm operates on a contingency fee basis, meaning shareholders are not responsible for upfront legal costs, which reduces the financial burden of pursuing rights and encourages broader shareholder participation.
  • Transparency Enhancement: By involving shareholders, Halper Sadeh LLC aims to improve the company's policies and oversight mechanisms, thereby increasing transparency and accountability, ultimately enhancing shareholder value.
  • Global Investor Support: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, showcasing its strength in protecting investor rights.
Businesswire
9.5
03-02Businesswire
DocGo to Release Q4 and Full Year 2025 Financial Results on March 16, 2025
  • Earnings Release Schedule: DocGo will announce its fourth quarter and full year financial results for the period ending December 31, 2025, after market close on March 16, 2025, highlighting the company's performance in medical transportation and mobile health services.
  • Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial results and outlook for 2026, which is expected to attract investor and analyst attention, enhancing the company's transparency.
  • Innovative Healthcare Platform: DocGo's technology-enabled medical transportation and mobile health services aim to reshape the traditional healthcare system by providing high-quality, accessible care that enhances patient experience and strengthens market competitiveness.
  • Telehealth Integration: DocGo's mobile health services facilitate patient treatment in collaboration with remote physicians, enabling care in the comfort of patients' homes or workplaces, and seamlessly bridging physical and virtual care through its medical transport services, thereby improving overall healthcare efficiency.
Wall Street analysts forecast DCGO stock price to rise
4 Analyst Rating
Wall Street analysts forecast DCGO stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
1.50
Averages
3.13
High
4.00
Current: 0.000
sliders
Low
1.50
Averages
3.13
High
4.00
Canaccord
Hold
downgrade
$1
AI Analysis
2026-03-25
Reason
Canaccord
Price Target
$1
AI Analysis
2026-03-25
downgrade
Hold
Reason
Canaccord lowered the firm's price target on DocGo to $1 from $1.50 and keeps a Hold rating on the shares. The firm updated is model following mixed Q4 results as revenue topped the high end of its guidance. DocGo has significant work left to do to scale its go-forward Mobile Health business and rightsize its cost structure to regain adj-EBITDA profitability targeted in 2H 2026. The formal process exploring strategic alternatives may deliver a positive outcome for shareholders, but fundamentally, Canaccord maintains its "show me" stance.
Stifel
Buy
maintain
$4
2026-03-17
Reason
Stifel
Price Target
$4
2026-03-17
maintain
Buy
Reason
Stifel lowered the firm's price target on DocGo to $2.50 from $4 and keeps a Buy rating on the shares. Q4 results were mixed and 2026 guidance was raised modestly to reflect improving growth in its transport segment, notes the analyst, who estimates transportation could potentially generate $15M-$20M of 2026 EBITDA pre-overhead and contends that this "implies this unit alone could yield proceeds above current share-price."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DCGO
Unlock Now

Valuation Metrics

The current forward P/E ratio for DocGo Inc (DCGO.O) is -2.19, compared to its 5-year average forward P/E of 29.00. For a more detailed relative valuation and DCF analysis to assess DocGo Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
29.00
Current PE
-2.19
Overvalued PE
62.16
Undervalued PE
-4.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
9.43
Current EV/EBITDA
-1.14
Overvalued EV/EBITDA
17.41
Undervalued EV/EBITDA
1.45

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.07
Current PS
0.31
Overvalued PS
1.68
Undervalued PS
0.45

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

lowest share costing stocks
Intellectia · 53 candidates
Market Cap: >= 50.00MRegion: USPrice: <= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
KALA logo
KALA
KALA BIO Inc
195.30M
MREO logo
MREO
Mereo BioPharma Group PLC
55.83M
SGMO logo
SGMO
Sangamo Therapeutics Inc
130.65M
OPTT logo
OPTT
Ocean Power Technologies Inc
86.12M
IMMP logo
IMMP
Immutep Ltd
54.23M
GOSS logo
GOSS
Gossamer Bio Inc
89.54M
list of strong buy stocks under $3.00
Intellectia · 94 candidates
Price: <= $3.00Analyst Consensus: Strong Buy
Ticker
Name
Market Cap$
top bottom
AKTX logo
AKTX
Akari Therapeutics PLC
9.32M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
RVPH logo
RVPH
Reviva Pharmaceuticals Holdings Inc
38.21M
INTS logo
INTS
Intensity Therapeutics Inc
23.85M
MREO logo
MREO
Mereo BioPharma Group PLC
84.34M
ATOS logo
ATOS
Atossa Therapeutics Inc
77.93M
let change to 10x potential
Intellectia · 18 candidates
Price: <= $1.00Relative Vol: >= 0.800Beta: HighRiskWeek Price Change Pct: $-5.00 - $100.00
Ticker
Name
Market Cap$
top bottom
ADV logo
ADV
Advantage Solutions Inc
260.01M
REI logo
REI
Ring Energy Inc
203.08M
FURY logo
FURY
Fury Gold Mines Ltd
136.18M
DCGO logo
DCGO
DocGo Inc
83.31M
MYPS logo
MYPS
PLAYSTUDIOS Inc
79.38M
CCG logo
CCG
Cheche Group Inc
69.46M
my source said it’s trading below $1
Intellectia · 38 candidates
Price: <= $1.00Weekly Average Turnover: >= 500,000Target Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
CAN logo
CAN
Canaan Inc
498.64M
DVLT logo
DVLT
Datavault AI Inc
433.82M
DEFT logo
DEFT
DeFi Technologies Inc
366.70M
NAKA logo
NAKA
Kindly MD Inc
283.65M
TRX logo
TRX
TRX Gold Corp
271.29M

Whales Holding DCGO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is DocGo Inc (DCGO) stock price today?

The current price of DCGO is 0.6324 USD — it has increased 5.33

What is DocGo Inc (DCGO)'s business?

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

What is the price predicton of DCGO Stock?

Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is3.13 USD with a low forecast of 1.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is DocGo Inc (DCGO)'s revenue for the last quarter?

DocGo Inc revenue for the last quarter amounts to 74.94M USD, decreased -37.98

What is DocGo Inc (DCGO)'s earnings per share (EPS) for the last quarter?

DocGo Inc. EPS for the last quarter amounts to -1.37 USD, increased 4466.67

How many employees does DocGo Inc (DCGO). have?

DocGo Inc (DCGO) has 2537 emplpoyees as of March 31 2026.

What is DocGo Inc (DCGO) market cap?

Today DCGO has the market capitalization of 59.24M USD.